Geode Capital Management
TEVA icon

Geode Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$160M Buy
9,629,526
+434,918
+5% +$7.24M 0.01% 752
2025
Q1
$141M Sell
9,194,608
-86,444
-0.9% -$1.32M 0.01% 783
2024
Q4
$204M Buy
9,281,052
+489,041
+6% +$10.7M 0.02% 632
2024
Q3
$158M Buy
8,792,011
+291,124
+3% +$5.22M 0.01% 721
2024
Q2
$138M Buy
8,500,887
+398,165
+5% +$6.44M 0.01% 739
2024
Q1
$114M Buy
8,102,722
+323,737
+4% +$4.55M 0.01% 844
2023
Q4
$80.9M Buy
7,778,985
+283,206
+4% +$2.94M 0.01% 1002
2023
Q3
$76.2M Buy
7,495,779
+349,180
+5% +$3.55M 0.01% 940
2023
Q2
$53.6M Buy
7,146,599
+394,037
+6% +$2.96M 0.01% 1196
2023
Q1
$59.6M Buy
6,752,562
+207,161
+3% +$1.83M 0.01% 1070
2022
Q4
$59.5M Sell
6,545,401
-87,713
-1% -$798K 0.01% 1035
2022
Q3
$53.4M Buy
6,633,114
+314,715
+5% +$2.54M 0.01% 1032
2022
Q2
$47.4M Buy
6,318,399
+230,504
+4% +$1.73M 0.01% 1173
2022
Q1
$57M Buy
6,087,895
+158,493
+3% +$1.48M 0.01% 1157
2021
Q4
$47.3M Buy
5,929,402
+207,724
+4% +$1.66M 0.01% 1354
2021
Q3
$55.5M Buy
5,721,678
+534,109
+10% +$5.18M 0.01% 1187
2021
Q2
$51.2M Buy
5,187,569
+486,108
+10% +$4.79M 0.01% 1285
2021
Q1
$54.1M Sell
4,701,461
-208,644
-4% -$2.4M 0.01% 1166
2020
Q4
$47.2M Buy
4,910,105
+580,306
+13% +$5.58M 0.01% 1136
2020
Q3
$38.9M Buy
4,329,799
+7,540
+0.2% +$67.7K 0.01% 1061
2020
Q2
$53.2M Buy
4,322,259
+36,558
+0.9% +$450K 0.01% 862
2020
Q1
$38.4M Buy
4,285,701
+28,019
+0.7% +$251K 0.01% 906
2019
Q4
$41.6M Buy
4,257,682
+87,581
+2% +$856K 0.01% 1058
2019
Q3
$28.6M Buy
4,170,101
+357,325
+9% +$2.45M 0.01% 1239
2019
Q2
$35.1M Buy
3,812,776
+560,511
+17% +$5.16M 0.01% 1090
2019
Q1
$50.9M Buy
3,252,265
+125,681
+4% +$1.97M 0.01% 830
2018
Q4
$48.1M Buy
3,126,584
+279,286
+10% +$4.3M 0.01% 757
2018
Q3
$61.2M Buy
2,847,298
+149,549
+6% +$3.21M 0.02% 712
2018
Q2
$65.5M Buy
2,697,749
+214,920
+9% +$5.21M 0.02% 643
2018
Q1
$42.3M Buy
2,482,829
+170,611
+7% +$2.91M 0.01% 813
2017
Q4
$43.7M Buy
2,312,218
+93,175
+4% +$1.76M 0.01% 772
2017
Q3
$39M Buy
2,219,043
+33,181
+2% +$583K 0.01% 795
2017
Q2
$72.5M Buy
2,185,862
+325,436
+17% +$10.8M 0.03% 538
2017
Q1
$59.6M Buy
1,860,426
+134,577
+8% +$4.31M 0.02% 573
2016
Q4
$62.5M Buy
1,725,849
+1,527,413
+770% +$55.3M 0.03% 532
2016
Q3
$9.13M Buy
198,436
+18,838
+10% +$866K ﹤0.01% 1557
2016
Q2
$9.02M Buy
179,598
+3,064
+2% +$154K ﹤0.01% 1510
2016
Q1
$9.45K Sell
176,534
-7,401
-4% -$396 0.01% 1440
2015
Q4
$12.1M Buy
183,935
+1,787
+1% +$117K 0.01% 1228
2015
Q3
$10.3M Sell
182,148
-6,784
-4% -$383K 0.01% 1318
2015
Q2
$11.2M Buy
188,932
+11,221
+6% +$663K 0.01% 1336
2015
Q1
$11.1M Buy
177,711
+29,110
+20% +$1.81M 0.01% 1311
2014
Q4
$8.55M Buy
148,601
+25,106
+20% +$1.44M 0.01% 1460
2014
Q3
$6.64M Buy
123,495
+24,416
+25% +$1.31M ﹤0.01% 1578
2014
Q2
$5.19M Buy
99,079
+23,688
+31% +$1.24M ﹤0.01% 1768
2014
Q1
$3.98M Buy
75,391
+23,670
+46% +$1.25M ﹤0.01% 1918
2013
Q4
$2.07M Sell
51,721
-4,311
-8% -$173K ﹤0.01% 2269
2013
Q3
$2.12M Buy
56,032
+8,368
+18% +$316K ﹤0.01% 2135
2013
Q2
$1.87M Buy
+47,664
New +$1.87M ﹤0.01% 2079